Pfizer completed acquisition of Seagen for $43 billion
On Dec. 14, 2023, Pfizer announced it had completed the acquisition of Seagen, a global biotechnology company based…
On Dec. 14, 2023, Pfizer announced it had completed the acquisition of Seagen, a global biotechnology company based…
On Dec. 14, 2023, the Department of Energy’s (DOE) Pacific Northwest National Laboratory (PNNL) announced that it had…
On Dec. 14, 2023, The Coalition for Epidemic Preparedness Innovations (CEPI) and PATH today announced a renewed collaboration…
On Dec. 14, 2023, the University of Alberta announced that a study published in Nature sheds light on…
On Dec. 14, 2023, Biogen and Sage Therapeutics announced ZURZUVAE (zuranolone) 50 mg (two 25 mg capsules per…
On Dec. 13, 2023, for the first time ever, an international team of researchers announced they had created…
On Dec. 13, 2023, National Institute of Allergy and Infectious Diseases (NIAID) scientists announced findings published in the…
On Dec. 13, 2023, the Allen Institute and collaborators announced that after six years and 32 million cells,…
On Dec. 13, 2023, in a study of historic scale, scientists at Gladstone Institutes announced that they had…
On Dec. 11, 2023, the U.S. Centers for Disease Control and Prevention (CDC) issued a Health Alert Network…
On Dec. 8, 2023, bluebird bio announced the U.S. commercial launch of its LYFGENIA’ (lovotibeglogene autotemcel, also known…
On Dec. 8, 2023, the U.S. Food and Drug Administration (FDA) approved two milestone treatments, Casgevy and Lyfgenia,…
On Dec. 8, 2023, the University of Virginia broke ground Friday on the Paul and Diane Manning Institute…
On Dec. 8, 2023, Vertex Pharmaceuticals and CRISPR Therapeutics announced that the U.S. Food and Drug Administration (FDA)…
On Dec. 7, 2023, BioNTech announced that it had signed a multi-year strategic partnership with the State of…
On Dec. 7, 2023, the U.S. Food and Drug Administration reported that of the more than 116 medically…
On Dec. 6, 2023, Anixa Biosciences announced updated positive results from the Phase 1 clinical trial of its…
On Dec. 6, 2023, the federal government announced it had expanded the Home Test to Treat program, an…
On Dec. 6, 2023, the University of Missouri Research Reactor (MURR) announced they had completed its first commercial…
On Dec. 5, 2023, Novartis announced that the U.S. Food and Drug Administration (FDA) had approved Fabhalta (iptacopan)…
On Dec. 5, 2023, Novavax announced that Health Canada had granted expanded authorization for Nuvaxovid XBB.1.5 Vaccine (Recombinant…
On Dec. 4 2023, the University of Wisconsin-Madison researchers announced that while analyzing data from wastewater samples collected…
On Dec. 3, 2023, the Bill & Melinda Gates Foundation announced that global donors at COP28 had pledged…
On Dec. 1, 2023, the World Health Organization (WHO) announced that the International Health Regulations National Focal Point…
On Nov. 30, 2023, the U.S. Department of Department of Agricultureメs (USDA) Animal and Plant Health Inspection Service…
On Nov. 30, 2023, in a momentous landmark for medical research, UK Biobank announced that it had unveiled…
On Nov. 30, 2023, researchers at Tufts University announced they had created tiny biological robots that they call…
On Nov. 30, 2023, researchers at Hokkaido University, in collaboration with colleagues at Woods Hole Oceanographic Institution announced…
On Nov. 29, 2023, Novavax’s partner, SK bioscience, announced that Novavax’s updated COVID-19 vaccine (NVX-CoV2601) had received Emergency…
On Nov. 29, 2023, the BC Centre for Disease Controlr Disease Control (BCCDC) announced that a A passenger…